norfloxacin has been researched along with Bronchitis in 5 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-three patients admitted to hospital with acute purulent exacerbations of chronic bronchitis were treated with 400 mg pefloxacin twice daily for ten days." | 7.67 | Pefloxacin in acute exacerbations of chronic bronchitis. ( Davies, BI; Maesen, FP; Teengs, JP, 1985) |
| "Forty-three patients admitted to hospital with acute purulent exacerbations of chronic bronchitis were treated with 400 mg pefloxacin twice daily for ten days." | 3.67 | Pefloxacin in acute exacerbations of chronic bronchitis. ( Davies, BI; Maesen, FP; Teengs, JP, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shah, P | 1 |
| Morita, H | 1 |
| Tomoda, T | 1 |
| Araki, K | 1 |
| Kurashige, T | 1 |
| Nishibayashi, Y | 1 |
| Matsumoto, K | 1 |
| Zushi, N | 1 |
| Davies, BI | 3 |
| Maesen, FP | 3 |
| Teengs, JP | 3 |
| Baur, C | 2 |
5 other studies available for norfloxacin and Bronchitis
| Article | Year |
|---|---|
[Do tendon lesions occur during quinolone administration?].
Topics: Achilles Tendon; Adult; Age Factors; Anti-Infective Agents; Bronchitis; Ciprofloxacin; Enzyme Inhibi | 2003 |
[Clinical efficacy and safety of norfloxacin tablets in pediatrics].
Topics: Acute Disease; Administration, Oral; Adolescent; Age Factors; Bronchitis; Child; Child, Preschool; D | 1990 |
[New oral quinolone compounds in chronic bronchitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Cipr | 1986 |
Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
Topics: Anti-Infective Agents; Bacterial Infections; Bronchitis; Ciprofloxacin; Enoxacin; Female; Humans; Ma | 1986 |
Pefloxacin in acute exacerbations of chronic bronchitis.
Topics: Anti-Bacterial Agents; Bacteria; Bronchitis; Chronic Disease; Female; Humans; Kinetics; Male; Microb | 1985 |